Britain is ‘a terrible place’ to sell medicines, says drug firm executive
Sanofi’s market access chief urges ministers to come up with a roadmap to raise spending on new treatmentsBusiness live – latest updatesNils Pratley: UK must heed Bell’s big pharma warningA senior pharmaceuticals executive has called on the government to come up with a “proper” roadmap...
<p>Sanofi’s market access chief urges ministers to come up with a roadmap to raise spending on new treatments</p><ul><li><p><a href="https://www.theguardian.com/business/live/2025/sep/12/uk-gdp-report-economy-july-tariffs-inflation-consumer-confidence-business-live">Business live – latest updates</a></p></li><li><p><a href="https://www.theguardian.com/business/nils-pratley-on-finance/2025/sep/11/uk-government-must-heed-warns-over-big-pharma-investment">Nils Pratley: UK must heed Bell’s big pharma warning</a></p></li></ul><p>A senior pharmaceuticals executive has called on the government to come up with a “proper” roadmap for raising spending on new medicines, saying Britain is “not a good place” to develop or sell drugs.</p><p>Paul Naish, the UK head of market access for the French company Sanofi, said Britain was “at a critical point”.</p> <a href="https://www.theguardian.com/business/2025/sep/12/britain-terrible-place-sell-medicines-drug-firm-executive-sanofi">Continue reading...</a>
Read the full article at:
The Guardian World →